Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 20, 2022

SELL
$45.75 - $56.69 $560 Million - $694 Million
-12,249,376 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $270 Million - $400 Million
-6,534,246 Reduced 34.79%
12,249,376 $723 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $577 Million - $741 Million
-14,691,363 Reduced 43.89%
18,783,622 $808 Million
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $45.7 Million - $51.8 Million
1,272,869 Added 3.95%
33,474,985 $1.31 Billion
Q1 2021

May 07, 2021

BUY
$33.49 - $37.77 $8.52 Million - $9.6 Million
254,300 Added 0.8%
32,202,116 $1.29 Billion
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $102 Million - $130 Million
3,051,838 Added 10.56%
31,947,816 $1.28 Billion
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $19.5 Million - $22.9 Million
613,967 Added 2.17%
28,895,978 $1.18 Billion
Q2 2020

Aug 11, 2020

BUY
$30.12 - $36.54 $40.6 Million - $49.3 Million
1,349,012 Added 5.01%
28,282,011 $1.05 Billion
Q1 2020

May 28, 2020

BUY
$27.03 - $38.62 $11.8 Million - $16.9 Million
436,883 Added 1.65%
26,932,999 $1.03 Billion
Q4 2019

Jan 30, 2020

BUY
$32.92 - $37.36 $95.9 Million - $109 Million
2,913,496 Added 12.35%
26,496,116 $1.18 Billion
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $157 Million - $204 Million
4,833,540 Added 25.78%
23,582,620 $958 Million
Q2 2019

Jul 23, 2019

BUY
$36.98 - $41.52 $22.4 Million - $25.2 Million
606,700 Added 3.34%
18,749,080 $911 Million
Q1 2019

May 01, 2019

BUY
$37.5 - $41.2 $31.8 Million - $34.9 Million
847,500 Added 4.9%
18,142,380 $864 Million
Q4 2018

Jan 29, 2019

SELL
$38.47 - $43.86 $41.7 Million - $47.5 Million
-1,083,500 Reduced 5.9%
17,294,880 $849 Million
Q3 2018

Oct 29, 2018

SELL
$34.47 - $41.81 $58.9 Million - $71.5 Million
-1,710,097 Reduced 8.51%
18,378,380 $905 Million
Q2 2018

Jul 24, 2018

BUY
$32.98 - $35.16 $718,963 - $766,487
21,800 Added 0.11%
20,088,477 $811 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $960,491 - $1.11 Million
-30,100 Reduced 0.15%
20,066,677 $782 Million
Q4 2017

Jan 31, 2018

BUY
$33.26 - $35.29 $85.7 Million - $91 Million
2,578,100 Added 14.72%
20,096,777 $799 Million
Q3 2017

Oct 19, 2017

BUY
$31.0 - $34.15 $18.2 Million - $20 Million
585,600 Added 3.46%
17,518,677 $686 Million
Q2 2017

May 25, 2022

SELL
N/A
-585,600 Reduced 3.34%
16,933,077 $626 Million
Q2 2017

May 24, 2022

BUY
N/A
585,600 Added 3.46%
17,518,677 $0
Q2 2017

May 14, 2018

BUY
N/A
1,644,036 Added 10.75%
16,933,077 $626 Million
Q1 2017

Sep 07, 2022

SELL
N/A
-2,229,636 Reduced 12.73%
15,289,041 $538 Million
Q1 2017

May 24, 2022

BUY
N/A
2,229,636 Added 14.58%
17,518,677 $0
Q1 2017

May 14, 2018

BUY
N/A
285,300 Added 1.9%
15,289,041 $538 Million
Q4 2016

May 14, 2018

BUY
N/A
940,508 Added 6.69%
15,003,741 $505 Million
Q3 2016

May 25, 2022

SELL
N/A
-203,000 Reduced 1.42%
14,063,233 $487 Million
Q2 2016

May 25, 2022

BUY
N/A
14,824 Added 0.1%
14,266,233 $514 Million
Q1 2016

Sep 07, 2022

BUY
N/A
3,983,709 Added 38.8%
14,251,409 $422 Million
Q4 2015

Sep 07, 2022

BUY
N/A
7,455,418 Added 265.1%
10,267,700 $331 Million
Q1 2013

Sep 07, 2022

SELL
N/A
-213,990 Reduced 7.07%
2,812,282 $81.2 Million
Q4 2012

Sep 07, 2022

SELL
N/A
-7,997,358 Reduced 72.55%
3,026,272 $75.9 Million
Q3 2012

Sep 07, 2022

BUY
N/A
322,800 Added 3.02%
11,023,630 $274 Million
Q2 2012

Sep 07, 2022

BUY
N/A
269,100 Added 2.58%
10,700,830 $246 Million
Q1 2012

Sep 07, 2022

BUY
N/A
732,400 Added 7.55%
10,431,730 $236 Million
Q4 2011

Sep 07, 2022

BUY
N/A
738,641 Added 8.24%
9,699,330 $210 Million
Q3 2011

Sep 07, 2022

BUY
N/A
200,400 Added 2.29%
8,960,689 $158 Million
Q2 2011

Sep 07, 2022

SELL
N/A
-158,100 Reduced 1.77%
8,760,289 $180 Million
Q4 2010

Sep 07, 2022

BUY
N/A
8,918,389
8,918,389 $156 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sanders Capital, LLC Portfolio

Follow Sanders Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanders Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanders Capital, LLC with notifications on news.